Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 20/20 | 0.60 |
| ▸ | CIT | O14578 | 2/20 | 0.52 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.52 |
| ▸ | BMP2K | Q9NSY1 | 2/20 | 0.52 |
| ▸ | PRKCB | P05771 | 1/20 | 0.52 |
| ▸ | MYLK2 | Q9H1R3 | 1/20 | 0.52 |
| ▸ | AURKC | Q9UQB9 | 1/20 | 0.52 |
| ▸ | GAK | O14976 | 1/20 | 0.51 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | PRKG2 | Q13237 | 1/20 | 0.51 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28494743 | 1.00 | AAK1 (0.60) | AAK1CITMKNK1BMP2KPRKCB | |
| SCHEMBL28485136 | 0.87 | AAK1 (0.58) | AAK1CYP3A4 | |
| SCHEMBL28485139 | 0.87 | AAK1 (0.58) | AAK1CYP3A4 | |
| SCHEMBL28487959 | 0.86 | AAK1 (0.59) | AAK1CITMKNK1BMP2KROCK2 | |
| SCHEMBL28487961 | 0.86 | AAK1 (0.59) | AAK1CITMKNK1BMP2KROCK2 | |
| SCHEMBL28491952 | 0.85 | AAK1 (0.61) | AAK1CYP3A4PRKG2 | |
| SCHEMBL28491949 | 0.85 | AAK1 (0.61) | AAK1CYP3A4PRKG2 | |
| SCHEMBL28484970 | 0.84 | AAK1 (0.52) | AAK1CYP3A4 | |
| SCHEMBL28484969 | 0.84 | AAK1 (0.52) | AAK1CYP3A4 | |
| SCHEMBL28487457 | 0.82 | AAK1 (0.60) | AAK1ROCK2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115484951-A | AAK1 inhibitors for the treatment of viral infections | 莱西肯医药有限公司 | 2022-12-16 | — | — | CN | disclosed |